Home › BioMerieux Q4 Revenues Up 7 Percent, Aided by Strong FilmArray Sales

BioMerieux Q4 Revenues Up 7 Percent, Aided by Strong FilmArray Sales

Jan 19, 2017

NEW YORK (GenomeWeb) – BioMérieux today reported that its fourth quarter revenues rose 7 percent year over year, driven in large part by an uptick in revenues for its FilmArray molecular diagnostic products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Dec
12
Featured Webinar

Precision Metagenomics to Identify Patients at Risk for Invasive Infection

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.

What's Popular?

In Molecular Diagnostics

  1. Guardant Health to Launch Cell-Free DNA Assay for Cancer Recurrence Monitoring in 2019

    Premium

  2. Legislators Release New Draft Bill Incorporating FDA Ideas for Diagnostics Regulation

  3. SABCS 2018 Features Molecular Diagnostics Research

  4. PredictImmune Gains CE-IVD Mark for IBD Test

  5. Novacyt to Sell Cytology, Clinical Lab Units

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.